FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy
2019 · eLife · 133 citations
https://doi.org/10.7554/elife.47327
S
Sean Uryu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
77
Papers
2.8K
Citations
21
h-index
27
i10-index
Sean Uryu is an academic researcher from Pfizer (United States). The author has contributed to research in topics: Cell Adhesion Molecules Research & Protease and Inhibitor Mechanisms & Caveolin-1 and cellular processes. The author has an h-index of 21, co-authored 66 publications.
Papers by this author
worksInhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression
2012 · Clinical & Experimental Metastasis · 111 citations
https://doi.org/10.1007/s10585-012-9562-5
FAK activity protects nucleostemin in facilitating breast cancer spheroid and tumor growth
2015 · Breast Cancer Research · 56 citations
https://doi.org/10.1186/s13058-015-0551-x
Inducible FAK loss but not FAK inhibition in endothelial cells of PYK2-null mice activates p53 tumor suppressor to prevent tumor growth
2025 · Molecular Biology of the Cell · 3 citations
https://doi.org/10.1091/mbc.e24-12-0562
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat